ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Food and Drug Administration (FDA) 

5600 Fishers Lane

Rockville  Maryland  20857  U.S.A.
Phone: 888-463-6332 or 1-888-INFO-FDA (1-888-463-6332) Fax:


SEARCH JOBS
FDA Overview:

The Food and Drug Administration is one of the nation's oldest and most respected consumer protection agencies. This presentation will tell you about FDA's responsibilities, the tools we use to fulfill those responsibilities, and our priorities for improving the way we serve the public.

•Stated most simply, FDA's mission is:
- to promote and protect the public health by helping safe and effective products reach the market in a timely way,
- To monitor products for continued safety after they are in use, and
- To help the public get the accurate, science-based information needed to improve health.

FDA's Mission Statement

The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more affordable; and helping the public get the accurate, science-based information they need to use medicines and foods to improve their health.


 Key Statistics


Email:
Ownership: Private

Web Site: FDA
Employees:
Symbol: 
 



Industry
Government






 Company News
Dosing Errors With Cubist (MRK) Antibiotic Prompt FDA Warning 5/22/2015 6:39:08 AM
FDA Grants Orphan Drug Designation To Aura Biosciences’ Novel Treatment For Uveal Melanoma 5/21/2015 11:14:25 AM
KemPharm Completes Pre-NDA Meeting With FDA For KP201/APAP 5/21/2015 11:06:58 AM
IntelliPharmaCeutics Intends To Accelerate Its Rexista(TM) Oxycodone XR Development Program On The Basis Of Positive Feedback From The FDA 5/21/2015 10:26:01 AM
Tris Pharma, Inc. Announces The FDA Acceptance Of NDA For Dyanavel XR 5/21/2015 6:26:28 AM
AVEO Oncology (AVEO) Announces Presentation Of Final Results Of Extension Study 902 And FDA Regulatory Feedback For Advancing Tivozanib In Renal Cell Carcinoma 5/20/2015 12:29:20 PM
Alnylam (ALNY) Receives Orphan Drug Designation From The United States FDAFor Revusiran, An Investigational Rnai Therapeutic For The Treatment Of Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) 5/20/2015 12:06:36 PM
Lumicell Announces FDA Approval To Launch Feasibility Study 5/20/2015 11:40:39 AM
Bristol-Myers Squibb (BMY) Receives Amended FDA Breakthrough Therapy Designation For Investigational Daclatasvir-Based Hepatitis C Regimen 5/20/2015 11:20:57 AM
Eagle Pharmaceuticals (EGRX) Submits NDA For Ready-To-Use Bivalirudin To FDA 5/20/2015 11:19:12 AM
12345678910...